Intralesional acyclovir versus intralesional Hepatitis-B vaccine in treatment of resistant plantar warts: a randomized controlled trial
Authors:
Open Access
- 1 June 2024
- journal article
- research article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 316 (6) , 1-6
Abstract
Treating plantar warts is still a challenging problem with a long list of diverse treatment options that none of them seems to be definitive. To evaluate the effectiveness of intralesional acyclovir versus intralesional Hepatitis-B vaccine (HBV) in treatment of multiple resistant plantar warts. Forty-eight patients with resistant plantar warts completed the study with no dropouts. They were randomized into 3 groups; group(A) receiving intralesional HBV, group (B) receiving intralesional acyclovir and group (C) receiving intralesional saline as a control group over 5 biweekly sessions or until wart clearance. Clinical outcome was assessed through sequential digital lesion photographing upon each visit. Treatment related adverse reactions were recorded. 43.8%, 37.5% & 18.7% of Groups A, B &C respectively showed a complete response. pain was obvious in 100% and 56.3% of cases receiving intralesional acyclovir and HBV respectively. Up to the 6 month follow up period, none of the complete responders in all groups returned with a recurrence. Both acyclovir and HBV showed comparable efficacy and seem to be promising options for treating plantar warts being safe, affordable, and theoretically safe in immunocompromised cases.Keywords
Funding Information
- Zagazig University
This publication has 21 references indexed in Scilit:
- Hepatitis B virus vaccine: A potential therapeutic alternative for the treatment of wartsJournal of the American Academy of Dermatology, 2021
- Intralesional immunotherapy for the treatment of warts: A network meta-analysisJournal of the American Academy of Dermatology, 2019
- Intralesional Injection of the Measles-Mumps-Rubella Vaccine into Resistant Palmoplantar Wars: A Randomized Controlled Trial2019
- Morphological characteristics and human papillomavirus genotype predict the treatment response in cutaneous wartsBritish Journal of Dermatology, 2017
- Intralesional immunotherapy compared to cryotherapy in the treatment of wartsInternational Journal of Dermatology, 2017
- Oral Acyclovir in the Treatment of Verruca.2016
- Treatment of plantar warts with oral valacyclovirThe American Journal of Medicine, 2005
- Does acyclovir have an adjunctive role in plantar wart therapy?Cleveland Clinic Journal of Medicine, 1983
- Treatment of plantar warts with acyclovirThe American Journal of Medicine, 1982
- On the psyche and warts. I. Suggestion and warts: a review and comment.1959